ONDANSETRON ARROW 8 mg, orodispersible tablet 2 tablets
Active ingredients: Ondansetron
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet2 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONDANSETRON ARROW 8 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium PETP : copolymère de polytéréphta.d'éthlè.glycol et de diéthylè.glycol de 2 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Oct 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64961378CIP73781512CIP133400937815123Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONDANSÉTRONcomprimé | 8 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.